Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...

Clinical outcomes were similar across different viral ARIs among inpatients with hematologic malignancy or HSCTs.

March is MS Awareness Month, a nationwide campaign raising awareness about the chronic disease that affects 2.9 million people worldwide. IMSMP and Tisch MSRCNY serve as an example of the laboratory ...

SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration and improvements in ...

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that members of ...

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

LabConnect, a leading provider of technology-driven central laboratory services and functional service provider solutions for clinical trials, today announced the grand opening of its new facility in ...

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:00 PM EDTCompany ParticipantsNikhil Lalwani - ...

In fact, the one example that I am assuming you are citing ended up being exactly that. We have maintained service at all the facilities that we were serving, and it has given us an opportunity to ...

These coping strategies stop the spiral briefly, only to reinforce it over time.

Psychiatric diagnosis still relies on symptom checklists that were never designed to reflect biology. A peer-reviewed invited review published in Brain Medicine now synthesizes recent advances across ...